Kyonghoon Ahn

Kyonghoon Ahn currently serves as the Director at AffyXell Therapeutics, where he plays a pivotal role in advancing innovative cell and gene therapy platforms. His extensive background in cell line development, recombinant protein production, and protein engineering positions him as a key driver in the company’s efforts to develop next-generation biopharmaceuticals. At AffyXell, Kyonghoon oversees critical projects focused on optimizing bioprocesses for scalable production of therapeutic proteins and gene delivery vectors, ensuring that manufacturing processes meet stringent quality and regulatory standards.

His expertise in bio-process development and recombinant protein production is complemented by a strategic approach to research and business planning within the biotech sector. Kyonghoon actively contributes to technology evaluation and project planning, leveraging his skills in SOP development, process validation, and scientific research to streamline workflows and accelerate product development timelines. His proficiency in cell culture techniques, viral vector engineering, and translational research supports the company’s mission to deliver safe and effective cell and gene therapies.

In addition to his technical acumen, Kyonghoon is adept at integrating scientific insights with business strategies, fostering collaborations, and guiding multidisciplinary teams through complex project lifecycles. His leadership in cell & gene therapy research is underpinned by a comprehensive understanding of industry trends, regulatory landscapes, and innovative biotechnologies. With a focus on continuous improvement and scientific rigor, Kyonghoon Ahn is instrumental in positioning AffyXell Therapeutics at the forefront of the rapidly evolving biopharmaceutical landscape.